APA

Marmé F., Werft W., Walter A., Keller S., Wang X., Benner A., Burwinkel B., Sinn P., Hug S., Sohn C., Bretz N., Moldenhauer G., Rupp C., Rupp A., Biakhov M. Y., Bottini A., Friedrichs K., Khailenko V. A., Manikhas G. M., Ruiz A., Sánchez-Rovira P., Santoro A., Segui M. A., Villena C., Lichter P., Kristiansen G., Altevogt P. & Schneeweiss A. (20120822). CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. : Breast cancer research and treatment.

Chicago

Marmé Frederik, Werft Wiebke, Walter Anne, Keller Sascha, Wang Xiaoli, Benner Axel, Burwinkel Barbara, Sinn Peter, Hug Sarah, Sohn Christof, Bretz Niko, Moldenhauer Gerhard, Rupp Christian, Rupp Anne-Kathleen, Biakhov Mikhail Y, Bottini Alberto, Friedrichs Kay, Khailenko V A, Manikhas Georgiy M, Ruiz Amparo, Sánchez-Rovira Pedro, Santoro Armando, Segui Miguel A, Villena Carlos, Lichter Peter, Kristiansen Glen, Altevogt Peter and Schneeweiss Andreas. 20120822. CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. : Breast cancer research and treatment.

Harvard

Marmé F., Werft W., Walter A., Keller S., Wang X., Benner A., Burwinkel B., Sinn P., Hug S., Sohn C., Bretz N., Moldenhauer G., Rupp C., Rupp A., Biakhov M. Y., Bottini A., Friedrichs K., Khailenko V. A., Manikhas G. M., Ruiz A., Sánchez-Rovira P., Santoro A., Segui M. A., Villena C., Lichter P., Kristiansen G., Altevogt P. and Schneeweiss A. (20120822). CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. : Breast cancer research and treatment.

MLA

Marmé Frederik, Werft Wiebke, Walter Anne, Keller Sascha, Wang Xiaoli, Benner Axel, Burwinkel Barbara, Sinn Peter, Hug Sarah, Sohn Christof, Bretz Niko, Moldenhauer Gerhard, Rupp Christian, Rupp Anne-Kathleen, Biakhov Mikhail Y, Bottini Alberto, Friedrichs Kay, Khailenko V A, Manikhas Georgiy M, Ruiz Amparo, Sánchez-Rovira Pedro, Santoro Armando, Segui Miguel A, Villena Carlos, Lichter Peter, Kristiansen Glen, Altevogt Peter and Schneeweiss Andreas. CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer. : Breast cancer research and treatment. 20120822.